Latest news
Iconovo develops new formulations to strengthen the product portfolio (only in Swedish)
Breddat erbjudande med egen utveckling.
Iconovo AB (publ) utökar erbjudandet med egenutvecklade läkemedelsformuleringar för bolagets inhalatorer. Ett…
Iconovo at CPhI in Madrid
Iconovo attended CPhI in Madrid last week which marked the start of our new collaboration with Stevanato Group and ICOcap. Truly an exiting moment and…
Press releases
Dec 22, 2025, 10:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-listing
Dec 22, 2025, 10:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-listing
Dec 16, 2025, 12:45
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Other
mfn-cus-disclaimer
mfn-cus-top-disclaimer
mfn-ext-nq
mfn-ext-nq-corporate-action
Dec 16, 2025, 12:45
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Action
Other
mfn-cus-disclaimer
mfn-cus-top-disclaimer
mfn-ext-nq
mfn-ext-nq-corporate-action
Dec 15, 2025, 10:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
Nov 25, 2025, 21:15
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Nov 25, 2025, 21:05
News
IR
Swedish
Regulatory
MAR
Corporate Action
Other
mfn-cus-top-disclaimer
mfn-ext-nq
mfn-ext-nq-corporate-action
Nov 25, 2025, 21:05
News
IR
English
Regulatory
MAR
Corporate Action
Other
mfn-cus-top-disclaimer
mfn-ext-nq
mfn-ext-nq-corporate-action
Oct 31, 2025, 09:35
News
IR
English
Regulatory
MAR
Corporate Information
Staff change
Oct 14, 2025, 15:37
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-inside-information
Oct 14, 2025, 15:37
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-inside-information
Aug 13, 2025, 16:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-listing
Aug 13, 2025, 16:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-listing
Jun 11, 2025, 16:45
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-listing
Jun 11, 2025, 16:45
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-listing
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
CEO
Anders Månsson
Mail: anders.mansson@iconovo.se
Press releases
Follow us on Linkedin
